Skip to content

Apyx Medical Corporation APYX Oem — Interest Expense Nonoperating

Similar metrics at other companies

Twin Disc logo
TWINManufacturing — Interest Expense Nonoperating
$1.78M+25.5%
Altisource Portfolio Solutions logo
ASPSOrigination — Interest Expense, Nonoperating
$8K
Capricor Therapeutics logo
CAPRInterest Expense, Nonoperating
$761.43K
Flexible Solutions International logo
FSIInterest Expense Operating
$134.07K-32.3%
Richtech Robotics Inc. logo
RRInterest Expense, Nonoperating
$2K-50.0%
MAG
MAGNInterest Expense, Nonoperating
$35M-10.3%

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×
Current ratio5.8×+0.3×

Where this comes from

Reported directly by Apyx Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's oem — interest expense nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's oem — interest expense nonoperating?
Apyx Medical Corporation (APYX) reported oem — interest expense nonoperating of -$0 in Q1 2026.
What does oem — interest expense nonoperating mean?
This reflects interest expenses incurred by the OEM segment that are classified as non-operating in nature. It provides visibility into the cost of capital or debt servicing obligations specifically tied to the segment's financing structure.